Does the First Interview Matter: A Comparing Life Stress Interview Versus a Standard Psychiatric Intake Interview for Patients With Functional Somatic Disorder
1 other identifier
interventional
189
1 country
1
Brief Summary
Functional somatic syndromes (e.g. irritable bowel syndrome, fibromyalgia) and medically unexplained symptoms (e.g. chronic primary pain) are very common in primary care. These patients make 14 times more doctor visits than the general population, but describe themselves as less satisfied with the care they receive. Although Region Stockholm in Sweden recently developed care flows based on 'step up' care for the most common patient groups in primary care, patients with functional or medically unexplained symptoms are not mentioned. Short-term psychodynamic therapies such as Emotional Awareness and Expression Therapy (EAET) and Intensive Short Term Psychodynamic Therapy (ISTDP) have recently been evaluated in three systematic reviews and show good results for patients with medically unexplained symptoms. Short-term psychodynamic therapy considers that good treatment outcomes for patients with functional somatic syndromes can be achieved by increasing awareness of emotions and teaching patients to better experience, express and regulate emotions. In several randomized studies, short-term psychodynamic therapy has shown good effects even compared to other treatments, including cognitive behavioral therapy (CBT). The overall purpose of this research project is to to evaluate psychodynamic emotion-focused interventions (EAET and ISTDP) for patients with medically unexplained symptoms and high health care consumption. The project includes several studies that will clarify effects and contribute to information on how care flows in primary care for the patient group can be created. The research question for this specific study is: Can a therapeutic interview (so-called "EAET life-stress interview") focusing on emotional factors in comparison to a psychiatric interview (so-called "basic assessment") contribute to increased interest in psychological treatment and reduction of physical and psychiatric symptoms in patients with medically unexplained symptoms with relatively high health care consumption? Does the order of interview interventions matter?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 9, 2023
CompletedFirst Submitted
Initial submission to the registry
November 20, 2023
CompletedFirst Posted
Study publicly available on registry
November 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedApril 17, 2024
April 1, 2024
8 months
November 20, 2023
April 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Numeric Rating Scales according to EURONET-SOMA
Visual analogue scale 0-10 for symptom intensity and symptom interference. Higher scores indicates worse symptom/functioning.
Change from pre to follow up (6 weeks after interview)
PHQ-15
Ratings 0-2 on how troublesome somatic symptoms are experienced. Higher scores indicates worse symptom/functioning.
Change from pre to follow up (6 weeks after interview)
Secondary Outcomes (8)
Numeric Rating Scales according to EURONET-SOMA
Change from pre to post (within 1 week after interview)
PHQ-15
Change from pre to post (within 1 week after interview)
PHQ-9
Change from pre to post (within 1 week after interview) and follow up (6 weeks after interview)
GAD-7
Change from pre to post (within 1 week after interview) and follow up (6 weeks after interview)
PCL-5
Change from pre to post (within 1 week after interview) and follow up (6 weeks after interview)
- +3 more secondary outcomes
Study Arms (2)
Life stress interview/therapeutic interview
EXPERIMENTALRevised "Life stress interview" according to protocol from emotional awareness and expression therapy
Psychiatric interview
ACTIVE COMPARATORPsychiatric interview (M.I.N.I. etc) according to "Region stockholm - basutredning"
Interventions
This interview has the aim to jointly explore potential emotional factors contributing to patients functional somatic symptoms. While exploring this, it has the aim to not only describe such potential patterns but also emotionally process them.
This interview has the aim to gain enough information to diagnose some of the main psychiatric disorders
Eligibility Criteria
You may qualify if:
- The research subject certifies that he/she has undergone medical assessment for his/her physical symptoms.
- The subject must have visited a physician at least three times in the last year.
- The subject rates either moderate distress from bodily symptoms in the PHQ-15 (over 10 points) or severe distress from a single bodily symptom (at least 2 points for this symptom).
- The research participants expresses interest in investigating whether emotional factors such as stress may contribute to symptoms.
- Research subjects either affirm the presence of emotionally difficult life events (affirm at least 1 such event in the ACE-10 or reach the proposed cut-off point of 21p in the PCL-5).
- Drugs used should have been stable for at least 1 month.
You may not qualify if:
- Research subjects suffer from ongoing substance abuse (alcohol or drugs) or are deemed to have serious mental illness (psychotic illness, suicidal ideation, antisocial personality disorder etc).
- The research subjects have ongoing medication of a clearly addictive and sedative nature (e.g. benzodiazipines).
- The research subject participates in other psychological treatment focusing on physical symptoms. However, other psychological treatment is allowed where the support therapy does not take place more often than once a month.
- The research subject does not master the Swedish language sufficiently to be able to assimilate written material in Swedish.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Daniel Marotilead
- Wayne State Universitycollaborator
Study Sites (1)
Stockholm University
Stockholm, 10691, Sweden
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Lilliengren, PhD
Stockholm University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Researcher, Med.dr
Study Record Dates
First Submitted
November 20, 2023
First Posted
November 28, 2023
Study Start
October 9, 2023
Primary Completion
June 1, 2024
Study Completion
December 31, 2025
Last Updated
April 17, 2024
Record last verified: 2024-04